MIAMI FL. USA – March 8, 2010. The ASHVINS Group participated in an expert panel organized by the Office of Science and Engineering Laboratories, Center for Device and Radiological Health, U.S. Food and Drug Administration. The purpose of the panel was to review insulin pump safety issues in the context of pump operation; software; hardware; physical structure; electrical, biological, and chemical considerations; use; and environment from engineering and pump/user perspectives. The outcome of the project is summarized in two articles published in the Journal of Diabetes Science and Technology, Volume 4, Issue 2, March 2010; “Second Insulin Pump Safety Meeting: Summary Report” and “A Hazard Analysis for a Generic Insulin Infusion Pump”. The ASHVINS Group was selected by the FDA as an industry expert in the area of insulin pump technology to contribute in this panel of physicians, nurses, diabetes educators, and engineers from across the United States.